109 related articles for article (PubMed ID: 7497456)
1. Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors.
Frankfurt OS; Sugarbaker EV; Robb JA; Villa L
Cancer Lett; 1995 Nov; 97(2):149-54. PubMed ID: 7497456
[TBL] [Abstract][Full Text] [Related]
2. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
[TBL] [Abstract][Full Text] [Related]
3. Calmodulin antagonists inhibit apoptosis of CD4+ T-cells from patients with AIDS.
Pan G; Zhou T; Radding W; Saag MS; Mountz JD; McDonald JM
Immunopharmacology; 1998 Aug; 40(2):91-103. PubMed ID: 9826024
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin antagonists induce platelet apoptosis.
Wang Z; Li S; Shi Q; Yan R; Liu G; Dai K
Thromb Res; 2010 Apr; 125(4):340-50. PubMed ID: 20172594
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.
Pan G; Vickers SM; Pickens A; Phillips JO; Ying W; Thompson JA; Siegal GP; McDonald JM
Am J Pathol; 1999 Jul; 155(1):193-203. PubMed ID: 10393851
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.
Gulino A; Barrera G; Vacca A; Farina A; Ferretti C; Screpanti I; Dianzani MU; Frati L
Cancer Res; 1986 Dec; 46(12 Pt 1):6274-8. PubMed ID: 3022916
[TBL] [Abstract][Full Text] [Related]
7. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells.
El Etreby MF; Liang Y; Wrenn RW; Schoenlein PV
Breast Cancer Res Treat; 1998 Sep; 51(2):149-68. PubMed ID: 9879777
[TBL] [Abstract][Full Text] [Related]
8. The effect of calmodulin antagonists on scoliosis: bipedal C57BL/6 mice model.
Akel I; Demirkiran G; Alanay A; Karahan S; Marcucio R; Acaroglu E
Eur Spine J; 2009 Apr; 18(4):499-505. PubMed ID: 19242737
[TBL] [Abstract][Full Text] [Related]
9. Strong inhibition of neuronal nitric oxide synthase by the calmodulin antagonist and anti-estrogen drug tamoxifen.
Renodon A; Boucher JL; Sari MA; Delaforge M; Ouazzani J; Mansuy D
Biochem Pharmacol; 1997 Nov; 54(10):1109-14. PubMed ID: 9464453
[TBL] [Abstract][Full Text] [Related]
10. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
11. Fas binding to calmodulin regulates apoptosis in osteoclasts.
Wu X; Ahn EY; McKenna MA; Yeo H; McDonald JM
J Biol Chem; 2005 Aug; 280(33):29964-70. PubMed ID: 15965236
[TBL] [Abstract][Full Text] [Related]
12. Regulation of avian osteoclastic H+ -ATPase and bone resorption by tamoxifen and calmodulin antagonists. Effects independent of steroid receptors.
Williams JP; Blair HC; McKenna MA; Jordan SE; McDonald JM
J Biol Chem; 1996 May; 271(21):12488-95. PubMed ID: 8647856
[TBL] [Abstract][Full Text] [Related]
13. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
[TBL] [Abstract][Full Text] [Related]
14. The effect of calmodulin antagonists on experimental scoliosis: a pinealectomized chicken model.
Akel I; Kocak O; Bozkurt G; Alanay A; Marcucio R; Acaroglu E
Spine (Phila Pa 1976); 2009 Mar; 34(6):533-8. PubMed ID: 19282733
[TBL] [Abstract][Full Text] [Related]
15. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
Kang Y; Cortina R; Perry RR
J Natl Cancer Inst; 1996 Mar; 88(5):279-84. PubMed ID: 8614006
[TBL] [Abstract][Full Text] [Related]
16. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of cisplatin cytotoxicity in human ovarian carcinoma cell lines by trifluoperazine, a calmodulin inhibitor.
Perez RP; Handel LM; Hamilton TC
Gynecol Oncol; 1992 Jul; 46(1):82-7. PubMed ID: 1634144
[TBL] [Abstract][Full Text] [Related]
18. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity.
Mircheva J; Smith PJ; Bleehen NM
Br J Cancer; 1986 Jan; 53(1):99-103. PubMed ID: 2418860
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.
Sharp SY; Rowlands MG; Jarman M; Kelland LR
Br J Cancer; 1994 Sep; 70(3):409-14. PubMed ID: 8080723
[TBL] [Abstract][Full Text] [Related]
20. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
Musgrove EA; Wakeling AE; Sutherland RL
Cancer Res; 1989 May; 49(9):2398-404. PubMed ID: 2706627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
